Cancer genetics and genomics is a rapidly evolving field that focuses on understanding the genetic mutations and alterations that contribute to the development and progression of cancer. By studying the genetic makeup of both normal and cancerous cells, researchers are uncovering the underlying mechanisms that drive tumor formation. This knowledge is crucial for identifying specific biomarkers for early diagnosis, predicting treatment responses, and developing personalized therapies. Advances in genomic technologies, such as next-generation sequencing, have made it possible to analyze cancer genomes in unprecedented detail, paving the way for targeted therapies that can more effectively treat various types of cancer.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States